William P. Forbes - Chief Development Officer at Trevi Therapeutics, Inc.

Insider Transactions and Holdings

Class	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Stock Option (right to buy)	138K			Feb 11, 2022	Direct	Common Stock
Performance Stock Options (right to buy)	48K			Jun 29, 2022	Direct	Common Stock

Showing 1 to 2 of 2 entries

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.